$4.35 -0.1 -2.0%
Last Trade - 5:15pm
Market Cap | £68.3m |
Enterprise Value | £3.67m |
Revenue | £n/a |
Position in Universe | 5217th / 6854 |
Dec 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aprea Therapeutics, Beyondspring and Cognizant Technology Solutions on Tuesday. HIGHLIGHTS * Aprea Therapeutics Inc APRE.O : Baird cuts to neutral from outperform * Beyondspring Inc BYSI.O : Evercore ISI initiates coverage with outperform rating and $30 PT * Cognizant Technology Solutions Corp CTSH.O : Credit Suisse raises PT to $91 from $79 * Seer, Inc. SEER.O : JP Morgan initiates coverage with overweight rating; target $75 Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order. * Amphenol Corp APH.N : JP Morgan sets neutral rating with target price $138 * Aprea Therapeutics Inc APRE.O : Baird cuts target price to $5 from $45 * Aprea Therapeutics Inc APRE.O : Baird cuts to neutral from outperform * Aprea Therapeutics Inc APRE.O : JP Morgan cuts target price to $6 from $31 * Aprea Therapeutics Inc APRE.O : RBC cuts target price to $10 from $40 * Aprea Therapeutics Inc APRE.O : RBC cuts to sector perform from outperform * Arcturus Therapeutics Holdings Inc ARCT.O : Baird cuts target price to $69 from $79 * Arcturus Therapeutics Holdings Inc ARCT.O : Baird cuts to neutral from outperform * Beyondspring Inc BYSI.O : Evercore ISI initiates coverage with outperform rating and $30 PT * Cognizant Technology Solutions Corp CTSH.O : Credit Suisse raises PT to $91 from $79 * Kilroy Realty Corp KRC.N : Evercore ISI cuts target price to $65 from $66 * Myovant Sciences Ltd MYOV.N : JP Morgan raises target price to $38 from $30 * Seer, Inc. SEER.O : JP Morgan initiates coverage with overweight rating; target $75 * Sigilon Therapeutics, Inc. SGTX.O : Jefferies initiates coverage with buy rating; PT $60 (Compiled by Bengaluru Newsroom) ((Diaries@thomsonreuters.com))